A review finds post-miscarriage ultrasound heterogeneity is common and that symptoms, not endometrial thickness, should guide management after EPL.
News|Articles|October 2, 2025
Q3 recap: What's new in obstetrics and gynecology?
Author(s)Morgan Ebert
Fact checked by: Celeste Krewson, Assistant Editor
Take a quick look at everything you may have missed during the third quarter of 2025, including the latest FDA approvals, top stories, and exclusive interviews.
Advertisement
Advertisement
As we near the finish of 2025, the third quarter (Q3) has delivered major advancements across cervical cancer screening, infectious disease management, and preventive women’s health.
Related to this article
Marla Shapiro, MDCM, explains how OPTION-VMS actigraphy data corroborated patient-reported sleep improvements with fezolinetant (Veozah) as early as week 4.
Soma Mandal, MD, is launching “Mind, Body, & the Pause: the Perimenopause and Beyond Series” on Contemporary OB/GYN, featuring specialists from across Hackensack Meridian Health.
Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
A new study finds that low birth volume and unprofitability were strongly associated with both obstetric unit and full hospital closures between 2010 and 2023.
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Advertisement
Advertisement